Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Focus on Cancer

Avoiding Unnecessary Delays in Diagnosing Bladder Cancer

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Early diagnosis of bladder cancer is a significant step toward survival. Over the years, findings have suggested that women and African-Americans are particularly vulnerable to the disease, and often times, we are delayed in our diagnosis and subsequent treatment of these more highly susceptible populations. What are the most effective steps we can take to improve our recognition of bladder cancer earlier in its progression? Host Dr. Mark Nolan Hill welcomes Dr. Gary Steinberg, professor and vice chairman of urology, and director of urologic oncology at the University of Chicago Pritzker School of Medicine, to discuss the key issues relative to gender and race, as well as awareness among patients and primary care physicians toward prevention of a delayed diagnosis of bladder cancer.

Recommended
Details
Presenters
Comments
  • Overview

    Early diagnosis of bladder cancer is a significant step toward survival. Over the years, findings have suggested that women and African-Americans are particularly vulnerable to the disease, and often times, we are delayed in our diagnosis and subsequent treatment of these more highly susceptible populations. What are the most effective steps we can take to improve our recognition of bladder cancer earlier in its progression? Host Dr. Mark Nolan Hill welcomes Dr. Gary Steinberg, professor and vice chairman of urology, and director of urologic oncology at the University of Chicago Pritzker School of Medicine, to discuss the key issues relative to gender and race, as well as awareness among patients and primary care physicians toward prevention of a delayed diagnosis of bladder cancer.

Schedule6 Oct 2024